Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

EGX:MPCI Ratios and Metrics

Market cap in millions EGP. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	2,777	505	174	78	150	87
Market Cap Growth	232.42%	190.25%	123.70%	-48.16%	73.15%	74.83%
Enterprise Value	2,183	220	403	-31	123	49
Last Close Price	122.08	27.90	9.27	4.14	7.99	4.61
PE Ratio	6.93	2.64	1.93	1.05	3.59	4.98
PS Ratio	2.13	0.58	0.26	0.14	0.29	0.18
PB Ratio	4.20	3.39	1.66	2.13	-3.93	-1.10
P/TBV Ratio	4.24	3.60	1.88	3.79	-	-
P/FCF Ratio	18.49	3.18	3.75	3.31	107.03	-
P/OCF Ratio	15.77	2.76	3.01	2.13	43.26	-
EV/Sales Ratio	1.67	0.25	0.61	-	0.24	0.10
EV/EBITDA Ratio	4.86	1.11	3.89	-	2.81	2.32
EV/EBIT Ratio	5.07	1.19	4.21	-	3.61	4.25
EV/FCF Ratio	14.54	1.39	8.67	-	87.71	-
Debt / Equity Ratio	0.17	1.20	0.13	0.13	-0.14	-0.09
Debt / EBITDA Ratio	0.25	0.90	0.13	0.06	0.12	0.35
Debt / FCF Ratio	0.75	1.13	0.29	0.20	3.82	-
Asset Turnover	1.00	0.87	0.99	1.11	1.28	1.36
Inventory Turnover	2.42	2.41	2.29	2.41	2.60	4.00
Quick Ratio	1.37	0.90	0.71	0.39	0.23	0.24
Current Ratio	1.91	1.16	1.03	0.92	0.77	0.69
Return on Equity (ROE)	110.08%	150.74%	127.74%	-	-	-
Return on Assets (ROA)	20.61%	11.58%	8.91%	8.70%	5.27%	2.02%
Return on Capital (ROIC)	50.96%	51.96%	75.08%	1009.03%	-	-
Return on Capital Employed (ROCE)	56.30%	71.00%	88.10%	180.70%	-	-
Earnings Yield	14.43%	37.88%	51.93%	95.17%	27.84%	20.07%
FCF Yield	5.41%	31.42%	26.70%	30.25%	0.93%	-4.59%
Dividend Yield	3.28%	14.34%	21.59%	-	-	-
Payout Ratio	5.94%	6.35%	-	-	0.60%	-
Total Shareholder Return	-301.17%	14.34%	21.59%	-	-	-

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.